Literature DB >> 11039942

Evidence and belief in ADHD.

M Zwi, P Ramchandani, C Joughin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039942      PMCID: PMC1118810          DOI: 10.1136/bmj.321.7267.975

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Development of clinical services for attention-deficit/hyperactivity disorder.

Authors:  E Taylor
Journal:  Arch Gen Psychiatry       Date:  1999-12

Review 2.  Lessons from large trials: the MTA study as a model for evaluating the treatment of childhood psychiatric disorder.

Authors:  M H Boyle; A R Jadad
Journal:  Can J Psychiatry       Date:  1999-12       Impact factor: 4.356

3.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  1999-12

4.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

5.  Trends in the prescribing of psychotropic medications to preschoolers.

Authors:  J M Zito; D J Safer; S dosReis; J F Gardner; M Boles; F Lynch
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

6.  Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry.

Authors:  M Dulcan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-10       Impact factor: 8.829

  6 in total
  14 in total

1.  Evidence and belief in attention deficit hyperactivity disorder. Narrow focus of editorial was disappointing.

Authors:  S Timimi
Journal:  BMJ       Date:  2001-03-03

2.  A critique of the international consensus statement on ADHD.

Authors:  Sami Timimi; Joanna Moncrieff; Jon Jureidini; Jonathan Leo; David Cohen; Charles Whitfield; Duncan Double; Jonathan Bindman; Henry Andrews; Eia Asen; Pat Bracken; Barry Duncan; Michaele Dunlap; Galves Albert; Michael Green; Tom Greening; Janice Hill; Rhodri Huws; Bertram Karon; Brian Kean; Michael McCubbin; Begum Miatra; Loren Mosher; Sue Parry; S DuBose Ravenel; Dominick Riccio; Richard Shulman; Jeanne Stolzer; Phil Thomas; Graham Vimpani; Al Wadsworth; Dave Walker; Norbert Wetzel; Rupert White
Journal:  Clin Child Fam Psychol Rev       Date:  2004-03

3.  What is a disease?

Authors:  Jackie Leach Scully
Journal:  EMBO Rep       Date:  2004-07       Impact factor: 8.807

4.  Hyperactivity in children: the Gillberg affair.

Authors:  Jonathan Gornall
Journal:  BMJ       Date:  2007-08-25

5.  Attention-deficit/hyperactivity disorder: seeking the right balance between over- and undertreatment.

Authors:  Pieter J Hoekstra; Andrea Dietrich
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08       Impact factor: 4.785

6.  Methylphenidate: use in daily practice.

Authors:  Jacqueline G Hugtenburg; Judith E Griekspoor; Ingrid De Boer; Eibert R Heerdink; Yung Hwo Tso; Antoine C G Egberts
Journal:  Pharm World Sci       Date:  2005-06

7.  Altered biochemical parameters in saliva of pediatric attention deficit hyperactivity disorder.

Authors:  E Archana; Priya Pai; Bhavya K Prabhu; Revathi P Shenoy; Krishnananda Prabhu; Anjali Rao
Journal:  Neurochem Res       Date:  2011-10-01       Impact factor: 3.996

8.  No auditory conduction abnormality in children with attention deficit hyperactivity disorder.

Authors:  Neelam Vaney; Yumnam Anjana; Farah Khaliq
Journal:  Funct Neurol       Date:  2011 Jul-Sep

9.  Prevalence of methylphenidate use among Israeli children: 1998-2004.

Authors:  Shlomo Vinker; Rina Vinker; Asher Elhayany
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

10.  Prevalence of and change in the prescription of methylphenidate in Israel over a 2-year period.

Authors:  Yacov Fogelman; Shlomo Vinker; Nir Guy; Ernesto Kahan
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.